Literature DB >> 21917908

Blood pressure in a hypertensive mouse model of SLE is not salt-sensitive.

Keisa W Mathis1, Marcia Venegas-Pont, Chester W Masterson, Katie L Wasson, Michael J Ryan.   

Abstract

Systemic lupus erythematosus (SLE) is a risk factor for hypertension. Previously, we demonstrated that an established mouse model of SLE (female NZBWF1 mice) develops hypertension with renal inflammation and oxidative stress, both characteristics known as contributing mechanisms to the development of salt-sensitive hypertension. On the basis of this model, we hypothesized that blood pressure in SLE mice would be salt-sensitive. Thirty-week-old female SLE and control mice (NZW/LacJ) were fed 8% high-salt (HS) diet or normal diet (0.4% salt) for 4 wk. Plasma levels of double-stranded DNA (dsDNA) autoantibodies, a marker of SLE disease activity, were increased in SLE mice compared with controls (472 ± 148 vs. 57 ± 17 U/ml × 1,000, P < 0.001). HS did not alter dsDNA autoantibody levels in SLE or control mice. Mean arterial pressure was increased in SLE mice compared with controls (132 ± 3 vs. 118 ± 2 mmHg, P < 0.001) and was not significantly altered by the HS diet in either group. Similarly, albuminuria was higher in SLE mice compared with controls (10.7 ± 9.0 vs. 0.3 ± 0.1 mg/day) but was not significantly increased in SLE or control mice fed a HS diet. In summary, blood pressure during SLE is not salt-sensitive, and the HS diet did not adversely affect SLE disease activity or significantly augment albuminuria. These data suggest that renal inflammation and oxidative stress, characteristics common to both SLE and models of salt-sensitive hypertension, may have diverging mechanistic roles in the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917908      PMCID: PMC3213952          DOI: 10.1152/ajpregu.00386.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  30 in total

Review 1.  Renal inflammation, autoimmunity and salt-sensitive hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Martha Franco; Edilia Tapia; Yasmir Quiroz; Richard J Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-01       Impact factor: 2.557

Review 2.  Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort.

Authors:  M Petri
Journal:  Lupus       Date:  2000       Impact factor: 2.911

3.  Endothelial dysfunction and blood pressure variability in selected inbred mouse strains.

Authors:  Michael J Ryan; Sean P Didion; Deborah R Davis; Frank M Faraci; Curt D Sigmund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

4.  Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.

Authors:  B Rodríguez-Iturbe; H Pons; Y Quiroz; K Gordon; J Rincón; M Chávez; G Parra; J Herrera-Acosta; D Gómez-Garre; R Largo; J Egido; R J Johnson
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

5.  Cardiovascular risk factor screening in systemic lupus erythematosus.

Authors:  Adeeba Al-Herz; Stephanie Ensworth; Kamran Shojania; John M Esdaile
Journal:  J Rheumatol       Date:  2003-03       Impact factor: 4.666

6.  Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts.

Authors:  D Ba; N Takeichi; T Kodama; H Kobayashi
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

7.  Hypertension and renal disease in systemic lupus erythematosus.

Authors:  D R Budman; A D Steinberg
Journal:  Arch Intern Med       Date:  1976-09

8.  Immunological changes in patients with previous malignant essential hypertension.

Authors:  T Gudbrandsson; L Hansson; H Herlitz; L Lindholm; L A Nilsson
Journal:  Lancet       Date:  1981-02-21       Impact factor: 79.321

9.  Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.

Authors:  E M C Sella; E I Sato; W A Leite; J A Oliveira Filho; A Barbieri
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

10.  Vascular stiffness in women with systemic lupus erythematosus.

Authors:  F Selzer; K Sutton-Tyrrell; S Fitzgerald; R Tracy; L Kuller; S Manzi
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

View more
  27 in total

1.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

Review 2.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

3.  Preventing autoimmunity protects against the development of hypertension and renal injury.

Authors:  Keisa W Mathis; Kedra Wallace; Elizabeth R Flynn; Christine Maric-Bilkan; Babbette LaMarca; Michael J Ryan
Journal:  Hypertension       Date:  2014-07-14       Impact factor: 10.190

4.  Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.

Authors:  Erin B Taylor; Jennifer M Sasser; Kenji J Maeda; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

5.  Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.

Authors:  Victoria L Wolf; Taylor L Phillips; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

Review 6.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

7.  Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.

Authors:  Keisa W Mathis; Marcia Venegas-Pont; C Warren Masterson; Nicholas J Stewart; Katie L Wasson; Michael J Ryan
Journal:  Hypertension       Date:  2012-01-30       Impact factor: 10.190

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

9.  Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.

Authors:  Erin B Taylor; Michelle T Barati; David W Powell; Hannah R Turbeville; Michael J Ryan
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

10.  Temporal hemodynamic changes in a female mouse model of systemic lupus erythematosus.

Authors:  Elena L Dent; Erin B Taylor; Jennifer M Sasser; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.